BOSTON, Feb. 26 /PRNewswire-FirstCall/ -- Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce that the Company has received a significant purchase order for the MammoView(TM) line of surgical endoscopy instruments from Waterbury Hospital in Connecticut. The Waterbury Hospital, the cornerstone of the Greater Waterbury Health Network, has been providing the local community with health care services since 1983 and is accredited by the Joint Commission on the Accreditation of Healthcare Organizations.
Waterbury Hospital is a not-for-profit, acute care teaching hospital offering complete inpatient and outpatient services to the community. Some of the services that the hospital offers are Advanced Care, Behavioral Health, Emergency Health, Cardiopulmonary, Orthopedic, etc. Some of the organizations that are affiliates with the Greater Waterbury Health Network are Access Rehab Centers, Alliance Medical Group, and the Harold Leever Regional Cancer Center, amongst others.
"We are pleased to be providing our MammoView product line to Waterbury Hospital and their expansive healthcare network. Our endoscopy surgical instruments are top of the line and we expect to receive more orders from healthcare facilities around the country," stated Bob Segersten, President of Solos Endoscopy, Inc.
For more information on Waterbury Hospital, please visit http://www.waterburyhospital.org/.
About Solos Endoscopy, Inc.:
Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office. Additional information is available on the Company's website at: www.solosendoscopy.com.
Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
|SOURCE Solos Endoscopy, Inc.|
Copyright©2009 PR Newswire.
All rights reserved